| Tengion advances in neo-urinary conduit neo-kidney augment programmes - pharmabiz.com |
|
|
pharmabiz.com This increase in functional kidney mass could thereby delay or prevent the need for dialysis or kidney transplant in patients with end stage renal disease (ESRD). According to the United States Renal Data System, more than $27 billion in Medicare costs |